Journals / Turkish Journal of Gastroenterology / 2021 / Cilt: 32 - Sayı: 7

Bone Mineral Density Screening and the Frequency of Osteopenia/Osteoporosis in Turkish Adult Patients With Celiac Disease

Pages
600–607
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is important for all patients with CD to undergo a DEXA scan to determine the follow-up and/or treatment characteristics.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: The aim of this study was to evaluate the prevalence of osteopenia and osteoporosis in adult patients with celiac disease (CD) at diagnosis and/or in the follow-up after a gluten-free diet (GFD).
📊
Key Findings & Data:The mean age of the patients at diagnosis was 34.61 ± 10.3 years, and 84% of the patients (n = 84) were female.
💡
Conclusion & Impact:It is important for all patients with CD to undergo a DEXA scan to determine the follow-up and/or treatment characteristics.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background: The aim of this study was to evaluate the prevalence of osteopenia and osteoporosis in adult patients with celiac disease (CD) at diagnosis and/or in the follow-up after a gluten-free diet (GFD). Methods: Adult patients diagnosed with CD were retrospectively screened through follow-up records and computer databases. Patients assessed by dual-energy X-ray absorptiometry (DEXA) at diagnosis and/or in the follow-up after a GFD were included in the study. Results: One hundred patients who underwent a DEXA scan at least once after diagnosis or after being on a GFD were included in the study. The mean age of the patients at diagnosis was 34.61 ± 10.3 years, and 84% of the patients (n = 84) were female. At the time of diagnosis (n = 46), the prevalence of osteopenia and osteoporosis was 67.3% and 15.2%, respectively, at the lumbar spine, and 43.4% and 10.8%, respectively, at the femur. After a GFD (n = 78), the prevalence of osteopenia and osteoporosis was 61.5% and 8.9%, respectively, at the lumbar spine, and 37.1% and 2.5%, respectively, at the femur. Conclusion: The prevalence of CD patients with low bone mineral density (BMD) is high after diagnosis and in the follow-up after a GFD. It is important for all patients with CD to undergo a DEXA scan to determine the follow-up and/or treatment characteristics.

🔖

Cite This Article

SAYAR, S., AYKUT, H., KAYA, Ö., KÜRBÜZ, K., AK, Ç., GÖKÇEN, P., BİLGİÇ, N. M., ADALI, G., KAHRAMAN, R., DOĞANAY, H. L., OZDIL, K. (2021). Bone Mineral Density Screening and the Frequency of Osteopenia/Osteoporosis in Turkish Adult Patients With Celiac Disease. Turkish Journal of Gastroenterology, Cilt: 32 - Sayı: 7, 600–607. https://ajindex.com/articles/408633

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Di SabatinoA, CorazzaGR. Coeliac disease. Lancet. 2009;373:1480- 1493. [CrossRef] 2. Jericho H, Sansotta N, Guandalini S. Extraintestinal manifestations of celiac disease: effectiveness of the gluten-free diet. J Pediatr Gastroenterol Nutr. 2017;65:75-79. [CrossRef] 3. Oh HJ, Ryu KH, Park BJ, Yoon BH. Osteoporosis and osteoporotic fractures in gastrointestinal disease. J Bone Metab. 2018;25:213- 217. [CrossRef] 4. Walker MD, Williams J, Lewis SK et al. Measurement of forearm bone density by dual energy X-ray absorptiometry increases the prevalence of osteoporosis in men with celiac disease. Clin Gastroenterol Hepatol. 2020;18:99-106. [CrossRef] 5. Larussa T, Suraci E, Nazionale I et al. Bone mineralization in celiac disease. Gastroenterol Res Pract. 2012;2012:198025. [CrossRef] 6. Singh P, Garber JJ. Implementation and adherence to osteoporosis screening guidelines among coeliac disease patients. Dig Liver Dis. 2016;48:1451-1456. [CrossRef] 7. Fouda MA. Celiac disease-related osteopathy among Saudi celiac patients: are we adherent to recommendations? Saudi J Gastroenterol. 2017;23:291-295. [CrossRef] 8. Camacho PM, Petak SM, Binkley N et al. American association of clinical endocrinologists and american college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis - 2016--executive summary. Endocr Pract. 2016;22:1111-1118. [CrossRef] 9. Abdallah Ismail N. Avoiding the under-diagnosis of low bone mineral density in egyptian children with chronic medical conditions affecting bone health. Arch Med Sci. 2011;7:700-705. [CrossRef] 10. Singh P, Arora A, Strand TA et al. Global Prevalence of celiac disease: systematic Reviewa nd Meta-analysis. Clin Gastroenterol Hepatol. 2018;16:823-836.e2. [CrossRef] 11. Tatar G, Elsurer R, Simsek H et al. Screening of tissue transglutaminase antibody in healthy blood donors for celiac disease screening in the Turkish population. Dig Dis Sci. 2004;49:1479-1484. [CrossRef] 12. Sezgin O, Sarıtaş B, Aydın İ, Şaşmaz T, Lınke ES. Celiac disease prevalence in Turkey: a population based cross-sectional study. Acta Med Mediterr. 2016;32:719. 14. Reilly NR, Fasano A, Green PH. Presentation of celiac disease. Gastrointest Endosc Clin N Am. 2012;22:613-621. [CrossRef] 13. Rubio-Tapia A, Hill ID, Kelly CP et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656-76; quiz 677. [CrossRef] 15. Selby PL, Davies M, Adams JE, Mawer EB. Bon